Comparison of generic health survey SF-36 and arrhythmia related symptom severity check list in relation to post-therapy AF recurrence

Europace

Volumn 5, Issue 4, 2003, Pages 351-355

  Berkowitsch, Alexander ^a   Neumann, T ^a   Kurzidim, K ^a   Reiner, C ^a   Kuniss, M ^a   Siemon, G ^a   Sperzel, J ^a   Pitschner, H F ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

Atrial fibrillation; Catheter ablation; Pulmonary vein isolation; Quality of life

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACCURACY; ADULT; AGED; ARTICLE; CALCULATION; CATHETER ABLATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISOLATION PROCEDURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY VEIN; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENCE RISK; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PULMONARY VEINS; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0242302628     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1099-5129(03)00089-8     Document Type: Article

References (9)

1. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996; 94: 1585-91.
2. Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001; 12: 900-8.
3. Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 2000; 101: 1138-44.
4. Lee SH, Tai CT, Yu WC, et al. Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. Am J Cardiol 1999; 84: 278-83.
5. Lee SH, Chen SA, Tai CT, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998; 31: 637-44.
6. Wood MA, Kay GN, Ellenbogen KA. The North American experience with the Ablate and Pace Trial (APT) for medically refractory atrial fibrillation. Europace 1999; 1: 22-5.
7. Dorian P, Paquette M, Newman D, et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002; 143: 984-90.
8. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789-94.
9. Lonnerholm S, Blomström P, Nilsson L, et al. Effects of the MAZE operation on health-related quality of life in patients with atrial fibrillation. Circulation 2000; 101: 2607-11.